Vivasure Medical Announces Acquisition by Haemonetics Corporation [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
vessel closure, today announced that the company has been acquired by Haemonetics Corporation (NYSE: HAE) in a transaction valued up to €185M (~$215M) on completion of certain milestones. Based in Galway, Ireland, Vivasure is focused on the development of advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology, and vascular surgery. In 2022, Vivasure Medical received a strategic investment from Haemonetics, which included an option to acquire Vivasure Medical. Earlier this year, Vivasure Medical announced the submission of a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its PerQseal ® Elite vascular closure system for arterial procedures, building upon the successful results of the PATCH study as well as positive clinical use in Europe. The company previously received European CE mark approval for an expanded indication for PerQseal Elite, covering large
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $90.00 to $93.00. They now have an "outperform" rating on the stock.MarketBeat
- EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics [Yahoo! Finance]Yahoo! Finance
- EQT Life Sciences to exit Vivasure Medical via sale to HaemoneticsPR Newswire
- Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.MarketBeat
- Vivasure Medical Announces Acquisition by Haemonetics CorporationBusiness Wire
HAE
Earnings
- 11/7/25 - Beat
HAE
Sec Filings
- 1/9/26 - Form 8-K
- 11/12/25 - Form 4
- 11/6/25 - Form 10-Q
- HAE's page on the SEC website